CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study

Publication | Closed Access

DOI

Citations

References

2017

Year

Sarita Rani Jaiswal, Shamsur Zaman, Murugaiyan Nedunchezhian, Aditi Chakrabarti, Prakash Bhakuni, Margoob Ahmed, Kanika Sharma, Sheh Rawat, Paul V. O’Donnell, Suparno Chakrabarti

Cytotherapy

Cell TherapyTransplantationMarrow TransplantationHaploidentical TransplantationStem Cell TransplantationHematologyImmunologyPost-transplantation CyclophosphamideAutoimmunityCell BiologyImmunotherapyMedicineCell TransplantationGraft RejectionPilot Study